Latest Share Purchase Plans News

Page 4 of 97
Recce Pharmaceuticals has cleared an active-comparator design for its pivotal Australian diabetic foot infection trial while an independent review of Indonesian Phase 3 data approaches. The biotech ended the quarter with A$1.04 million in cash, alongside expected tax rebates and unused financing facilities.
Victor Sage
Victor Sage
30 Oct 2026
ABx Group has completed its $2 million underwritten share purchase plan, with shareholders subscribing for $1.1 million and the remaining shortfall placed through the underwriter. The raising delivers fresh capital but also adds 95.2 million shares and 238.1 million options across the transaction.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Cyprium Metals has secured an approximately A$20.7 million institutional placement and outlined a proposed debt extension that could take its staged Nifty funding package to A$83 million. The capital is aimed at advancing the open-pit feasibility study, infrastructure upgrades and a major SXEW expansion while first cathode production remains targeted for Q4 2026.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Yandal Resources has locked in a $9 million placement and is seeking another $1 million from shareholders to accelerate drilling across its Western Australian gold projects. Gold Fields is expected to emerge with a 19.9% holding, while the raising will increase Yandal’s potential share count by roughly 35%.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Livium delivered its strongest lithium-ion battery collection quarter on record for FY26, lifting first-quarter revenue to A$1.84 million and gross profit to A$0.95 million. But operating cash flow remained negative at A$1.01 million, leaving the recycler with about 3.2 quarters of funding at the September quarter-end rate.
Victor Sage
Victor Sage
30 Oct 2026
OMG Group has confirmed its first positive quarterly EBITDA, with Q1 FY27 sales rising 59% to approximately $1.92 million and gross profit growing faster than revenue. The result marks an earnings milestone, but operating cash flow remained negative as the company invested heavily in inventory and supplier deposits.
Victor Sage
Victor Sage
30 Oct 2026
Bio-Gene Technology has moved closer to two commercialisation milestones, with Qcide product work progressing in Japan and a first Flavocide regulatory submission targeted for Q2 2027. The company ended September with A$2.103 million in cash, equivalent to an estimated 2.18 quarters of funding at the quarter’s operating cash rate.
Victor Sage
Victor Sage
30 Oct 2026
Botala Energy has achieved continuous gas flow from stimulated well 3.5B at its Serowe coal bed methane project in Botswana. The technical milestone comes with a significant funding constraint: cash stood at A$286,000 at quarter end, before a subsequent A$1.35 million placement and planned share purchase plan.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Talonx Resources has secured firm commitments for a discounted A$775,000 placement to expand exploration at its Kihabe copper project in Botswana and fund follow-up drilling at Viking’s Beaker 2 gold prospect. A proposed director tranche and Share Purchase Plan could provide additional funding, but both remain subject to further steps.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Canterbury Resources has launched a non-underwritten share purchase plan targeting $1 million, with the potential to raise up to $2.5 million for John Hill exploration and working capital. The funding push comes ahead of a planned Mineral Resource Estimate update in early 2027.
Maxwell Dee
Maxwell Dee
30 Oct 2026
TALi Digital closed its September quarter with $3.9 million in cash after completing a $3.3 million capital raise and winning shareholder approval for the Datasphere transaction. The company has also exercised an option to negotiate exclusive worldwide rights to Technion in-memory computing technology, although the licence remains unsigned and the technology unproven at commercial scale.
Victor Sage
Victor Sage
30 Oct 2026
Sparc Technologies has moved its graphene additive business from testing towards commercial adoption, with a first ecosparc® delivery to a tier 1 coatings manufacturer and more than 20 active qualification programs. The September quarter also delivered hydrogen progress and fresh funding, but the company reported only 1.14 quarters of cash coverage before subsequent receipts.
Sophie Babbage
Sophie Babbage
30 Oct 2026

Browse the archive

Full archive